Browse Category

Stock Market News 10 November 2025

Axia Energia debuts AXIA3; court declares Oi bankrupt; Kepler Weber gets R$11 offer — Brazil market wrap (Nov 10)

Axia Energia debuts AXIA3; court declares Oi bankrupt; Kepler Weber gets R$11 offer — Brazil market wrap (Nov 10)

São Paulo — November 10, 2025. Key points Axia Energia: new tickers on B3 and NYSE Axia Energia—Eletrobras’ new name—debuted its tickers on B3 this Monday: AXIA3 (common), AXIA5 (preferred A) and AXIA6 (preferred B). On the NYSE, the company’s ADRs now trade as AXIA (common) and AXIA PR (preferred), replacing EBR and EBR.B. Axia marked the change with a bell‑ringing ceremony at B3 around 9 a.m. (Brasília). At 10:45 a.m., AXIA3 rose 1.84% to R$59.76 while AXIA6 advanced 1.57% to R$62.92. InfoMoney B3’s own investor portal Bora Investir confirms the new codes and trading name (“AXIA ENERGIA”). A Citibank
Wall Street Rebounds: PCE In‑Line, Tariff Shock, and Fed‑Cut Bets — What It All Means (Sept. 26, 2025)

Japan Market Wrap (Nov 10): Sharp Lifts FY26 Outlook on PC Rush; Nikkei 225 Rebounds; BOJ Signals Near‑Term Rate Hike; Takaichi’s Stimulus Draft Targets Growth

Published: November 10, 2025 Key points Sharp jumps on PC upgrade cycle and raises FY26/03 outlook Electronics maker Sharp (6753) lifted guidance for the year ending March 2026 after a markedly stronger first half. April–September ordinary profit surged to roughly ¥33.6 billion (about 23× year‑on‑year), while net profit climbed to about ¥45.5 billion (+98% YoY). On the back of that performance, Sharp raised its full‑year forecasts to operating/ordinary profit ¥45 billion and net profit ¥53 billion (from ¥30 billion, ¥27 billion and ¥32 billion previously), while keeping revenue at ¥1.87 trillion. The company also kept the interim dividend suspended. s.kabutan.jp Management flagged outperformance in the PC business during
10 November 2025
Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Nikkei Jumps 635 Points as US Shutdown Deal Nears; Yen Softens, JGB Yields Rise, and 38 Japan Stocks Log All‑Time Highs (Nov. 10, 2025)

TOKYO — November 10, 2025 — Japan’s stock market rallied on Monday, lifted by progress in the U.S. Senate toward ending the record‑long federal government shutdown. The risk‑on tone pushed the Nikkei 225 up 635.39 points to 50,911.76, while the TOPIX added 0.56% to 3,317.42. The yen weakened toward ¥154 per dollar, and government bonds fell as yields edged higher. Tech and cyclical shares led gains, while some defensives lagged. Reuters Japan+2Reuters+2 Why markets surged today Global equities advanced after a key procedural vote in the U.S. Senate signaled momentum to reopen government agencies following a 40‑day shutdown. The potential
10 November 2025
Lenskart IPO Frenzy: Sky-High Valuation Meets Surging Demand – Will Investors See Big Gains?

Lenskart IPO Listing Today: Shares List at a Discount, Fall 11% Intraday, Then Close Above Issue Price — What It Means for Investors (Nov 10, 2025)

Dateline: Mumbai | November 10, 2025 India’s largest omni‑channel eyewear retailer Lenskart made a whipsaw stock‑market debut on Monday: the shares listed below the ₹402 issue price, plunged as much as 11% intraday, and then clawed back to finish slightly in the green by the closing bell. On the NSE, Lenskart closed at ₹404.55 (up 0.63% vs issue price), and at ₹403.30 on the BSE after opening at ₹395 and ₹390, respectively. The stock hit day’s lows of ₹356.10–₹355.70 before recovering, underscoring jittery sentiment around premium valuations. mint+1 What happened on Day 1 Why the listing stumbled despite a “bumper”
10 November 2025
Shutdown Drags On But Wall Street Hits Records – Here’s What’s Driving Markets

Asian Stocks Rebound on Tech Surge: Nikkei and Kospi Jump as U.S. Shutdown Breakthrough Lifts Sentiment—China Lags Despite CPI Tick-Up (Nov. 10, 2025)

Dateline: Tokyo/Seoul — November 10, 2025 Asian equities kicked off the week higher, led by a broad rebound in technology shares that powered gains in Japan and South Korea. The positive tone followed signs of progress in Washington toward ending a record U.S. government shutdown, a development that lifted global risk appetite and U.S. equity futures. Meanwhile, Chinese markets trailed despite fresh data showing inflation turning positive. ABC News+1 Key market moves What’s powering the rebound 1) Progress toward ending the U.S. shutdown:Global markets drew support from a U.S. Senate procedural vote advancing a funding package that would temporarily reopen
10 November 2025
Siemens Energy Hits Record Highs as Analysts Boost Targets: How AI, Grid Demand and a Wind Turnaround Drive the Stock Rally

Siemens Energy Soars After Jefferies Upgrade to €134; Commerzbank Jumps on Deutsche Bank ‘Buy’ as DAX Closes +1.65% (Nov 10, 2025)

Published: Monday, 10 November 2025 German equities rallied to start the week, led by Siemens Energy and Commerzbank after fresh analyst upgrades propelled both stocks to the top of the DAX. The benchmark index finished up 1.65% at 23,959.99, aided by broader risk-on sentiment as investors bet on progress in the U.S. budget impasse. Investing.com Deutsch Key takeaways Siemens Energy leads after Jefferies calls for €134 target Siemens Energy (Xetra: ENR) rallied after Jefferies shifted its rating to “Buy” and more than doubled its price target to €134. Analyst Lucas Ferhani argued the company’s product portfolio is positioned against the
10 November 2025
Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company (NYSE: LLY) opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and captured an analyst upgrade with a higher price target—moves that had LLY trading sharply higher intraday. Reuters+2 Today’s headlines at a glance Why the MeiraGTx move matters The MeiraGTx alliance hands Lilly a potential first‑in‑class therapy for LCA4 that, in a small study, has shown the ability to restore visual function in children born legally blind (regulators are evaluating expedited
Viasat (VSAT) Soars to a 52‑Week High on Analyst Upgrade; Earnings Beat and ViaSat‑3 F2 Launch Delay in Focus — Nov 10, 2025

Viasat (VSAT) Soars to a 52‑Week High on Analyst Upgrade; Earnings Beat and ViaSat‑3 F2 Launch Delay in Focus — Nov 10, 2025

Viasat, Inc. (NASDAQ: VSAT) rallied to a new 52‑week high on Monday after a fresh Outperform upgrade and $52 price target from Raymond James. The move extends gains from Friday’s Q2 FY2026 results, which showed an adjusted EPS beat and narrowing losses. Meanwhile, the ViaSat‑3 F2 satellite launch remains scrubbed pending a new date after back‑to‑back attempts last week. ulalaunch.com+4Investing.com+4Finviz+4 Today’s key developments (Nov 10, 2025) Earnings recap: Q2 FY2026 (reported Nov 7) Why it matters: The EPS beat—despite a slight revenue miss—supports the earnings‑power narrative as the company works through integration and capacity additions from the Inmarsat portfolio and
SoFi Technologies (SOFI) Stock Today — November 10, 2025: Price Action, Fresh 13F Moves, and What to Watch Next

SoFi Technologies (SOFI) Stock Today — November 10, 2025: Price Action, Fresh 13F Moves, and What to Watch Next

At a glance (Nov. 10, 2025) SOFI stock price today (real‑time snapshot) As of 15:49 UTC on Monday, Nov. 10, 2025, SoFi Technologies (NASDAQ: SOFI) was changing hands near $29–30, after opening at $29.06 and trading between $28.83 and $30.13 intraday on more than 33 million shares. TipRanks flagged elevated volatility and brisk options activity around SOFI today, noting a recent pullback after a strong rally and heavy call volume—context for the choppy tape. TipRanks Fresh items dated November 10, 2025 1) Institutional flows: Mitsubishi UFJ adds; Grange trims Why it matters: Rapid price moves often coincide with headline “position
10 November 2025
Stocks Today (Nov. 10, 2025): Nvidia Leads Big‑Tech Rebound; Futures Rise as Senate Moves to End Record Shutdown

Stocks Today (Nov. 10, 2025): Nvidia Leads Big‑Tech Rebound; Futures Rise as Senate Moves to End Record Shutdown

Big Tech snapped back to start the week as hopes for a Washington deal brightened the outlook and volatility eased. Here’s what moved markets today—Monday, November 10, 2025. What’s driving the move 1) Washington tailwinds: Senate procedural win Markets reacted to signs of progress toward ending the 40‑day government shutdown, the longest on record, after senators advanced a House‑passed bill that would fund the government into late January. Traders welcomed the possibility that official economic data could resume, helping the Federal Reserve and investors regain a clearer read on growth and inflation. Reuters 2) AI and megacaps reassert leadership Nvidia
10 November 2025
VTI & VOO Today (Nov. 10, 2025): Vanguard’s Broad‑Market ETFs Edge Higher on Shutdown Optimism—Latest Moves, Flows, and Why Young Investors Still Favor Them

VTI & VOO Today (Nov. 10, 2025): Vanguard’s Broad‑Market ETFs Edge Higher on Shutdown Optimism—Latest Moves, Flows, and Why Young Investors Still Favor Them

In Monday trading (Nov. 10, 2025), Vanguard’s Total Stock Market ETF (VTI) and S&P 500 ETF (VOO) ticked higher alongside equities as progress toward a U.S. government‑funding deal buoyed sentiment. As of ~15:24 UTC, VTI traded around $333.79 (≈+1.1% on the day). Markets were mixed to modestly positive, with the S&P 500 up ~0.1% and the Nasdaq down ~0.2% on the session. Nasdaq+1 What’s moving VTI and VOO today Fresh data points on VTI (Nov. 10) TipRanks’ VTI ETF Daily Report (11/10/2025) highlights that: Why it matters: The combination of continued leadership from mega‑cap tech plus steady net inflows reinforces
10 November 2025
Palantir (PLTR) Jumps as Burry–Karp Spat Heats Up: Fresh Q3 Numbers, Lofty Valuation, and the Bull‑vs‑Bear Case — Nov. 10, 2025

Palantir (PLTR) Jumps as Burry–Karp Spat Heats Up: Fresh Q3 Numbers, Lofty Valuation, and the Bull‑vs‑Bear Case — Nov. 10, 2025

Palantir stock is trading higher today after a bruising post‑earnings pullback last week, even as Wall Street remains sharply divided over the AI contractor’s sky‑high valuation. What’s new today (Nov. 10) Q3 by the numbers: acceleration across the board Palantir’s Q3 revenue rose 63% year over year to $1.18B, with U.S. commercial revenue up 121% to $397M and U.S. government revenue up 52% to $486M—a mix shift the company says is being propelled by its AI Platform (AIP). Slides also highlight a Rule‑of‑40 score of 114% and U.S. commercial total contract value (TCV) of $1.3B, +342% y/y. investors.palantir.com+3Reuters+3investors.palantir.com+3 Guidance: Management
10 November 2025
VGT vs. XLK Today (Nov. 10, 2025): Tech ETF Sell‑Off, Rebound, and Whether to Cut or Double Down

VGT vs. XLK Today (Nov. 10, 2025): Tech ETF Sell‑Off, Rebound, and Whether to Cut or Double Down

Tech’s rough first week of November gave way to a rebound today. We break down what’s moving the Vanguard Information Technology ETF (VGT) and the Technology Select Sector SPDR (XLK), how they differ under the hood, and what fresh research says about concentration risk, costs, and diversification. Key takeaways Why today matters What the latest research says about VGT and XLK (Nov. 2025) Bottom line from the coverage: breadth versus precision. VGT’s bigger roster can smooth single‑name shocks, while XLK is a pure S&P 500 tech‑sector slice with laser‑focused large‑cap exposure. Under the hood: where VGT and XLK really differ
10 November 2025
Vivakor (VIVK) Executes $23M LPG Trade Under $40M Credit Facility — What It Means for Investors Today (Nov. 10, 2025)

Vivakor (VIVK) Executes $23M LPG Trade Under $40M Credit Facility — What It Means for Investors Today (Nov. 10, 2025)

What happened today (Nov. 10, 2025) Vivakor, Inc. (Nasdaq: VIVK) announced that its trading arm, Vivakor Supply & Trading, has kicked off its first LPG transaction—approximately $23 million in contract value—under the company’s $40 million intermediation credit facility. Management framed the deal as a “significant operational milestone” that expands the platform into broader petroleum commodities while relying on Vivakor’s logistics and midstream footprint for transportation, gathering and execution. GlobeNewswire Why it matters How today’s news fits the recent timeline By the numbers Market reaction & read-through Shares of VIVK are higher today on the announcement. The investment takeaway is less
10 November 2025
Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Shares of Metsera, Inc. (NASDAQ: MTSR) slumped on Monday after the obesity‑drug developer said it will proceed with a sweetened takeover by Pfizer that ends a high‑stakes bidding war with Novo Nordisk. Metsera accepted Pfizer’s revised offer late Friday; Novo dropped out over the weekend. In early U.S. trading today, MTSR fell ~15% as investors recalibrated expectations around the final deal structure. Key takeaways (Nov. 10) What changed today The revised terms, line by line (from today’s 8‑K) Metsera’s Form 8‑K filed this morning lays out material changes versus the September agreement: Why Novo bowed out — and the FTC’s
Cogent Biosciences (COGT) soars ~115% after PEAK Phase 3 shows 16.5‑month PFS in GIST; NDA targeted for 1H 2026 (Nov. 10, 2025)

Cogent Biosciences (COGT) soars ~115% after PEAK Phase 3 shows 16.5‑month PFS in GIST; NDA targeted for 1H 2026 (Nov. 10, 2025)

Cogent Biosciences (NASDAQ: COGT) announced positive top‑line results from its Phase 3 PEAK trial testing bezuclastinib plus sunitinib in second‑line gastrointestinal stromal tumor (GIST), sending the stock sharply higher in Monday trading. The combination delivered a median progression‑free survival (mPFS) of 16.5 months vs. 9.2 months for sunitinib alone (HR=0.50; 95% CI 0.39–0.65; p<0.0001) and a 46% objective response rate vs. 26% on sunitinib monotherapy (p<0.0001). GlobeNewswire “It is a historic day for Cogent Biosciences and the GIST patient community,” CEO Andrew Robbins said, adding that the bezuclastinib combination “is poised to become the new standard of care” in second‑line
IMTE Stock Today: Nasdaq Delisting Clock Hits Nov. 10—Shares Trade as Hearing Stay Appears in Effect

IMTE Stock Today: Nasdaq Delisting Clock Hits Nov. 10—Shares Trade as Hearing Stay Appears in Effect

Integrated Media Technology Limited (NASDAQ: IMTE) faced a scheduled Nasdaq suspension and delisting on Nov. 10, 2025, over a late 20‑F. Shares were trading at the open, suggesting a short automatic stay tied to a Nasdaq hearing request. Here’s the status, timeline, and what investors should watch next. Key takeaways Stock snapshot (intraday) As of ~14:34 UTC (9:34 a.m. ET), IMTE was actively trading with heavy volume. At a glance: Price ~$1.06; day’s range ~$0.88–$2.32; intraday volume ~51.8M. (Live exchange data via widget above.) What happened and when (the timeline) Editor’s context: Several outlets and market pages recapped the Oct.
10 November 2025
Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

What Happened Movano Inc. (NASDAQ: MOVE) and Corvex, Inc., a GPU‑accelerated AI cloud company, signed a definitive all‑stock merger agreement. The combined business will focus squarely on secure, high‑performance AI infrastructure—including GPU clusters for training/inference, confidential computing, and inference‑as‑a‑service—repositioning Movano away from consumer health wearables. Upon closing, “Movano Inc.” will be renamed “Corvex, Inc.” and move its headquarters to Arlington, Virginia. PR Newswire The boards of both companies have unanimously approved the transaction, which is targeted to close in Q1 2026, subject to customary approvals, Nasdaq listing conditions for the new shares, and the effectiveness of an S‑4 registration statement.
Opendoor (OPEN) today — Nov. 10, 2025: JPMorgan calls a ‘major transformation,’ while investors weigh a $1.2B note repurchase, 180.6M‑share sale, and a new tradable‑warrants dividend

Opendoor (OPEN) today — Nov. 10, 2025: JPMorgan calls a ‘major transformation,’ while investors weigh a $1.2B note repurchase, 180.6M‑share sale, and a new tradable‑warrants dividend

What changed today (Nov. 10) JPMorgan’s take: In a note highlighted this morning, JPMorgan described Opendoor’s strategy reset as a “major transformation,” maintaining a positive stance and pointing to a volume‑driven plan (clear legacy inventory, accelerate acquisitions) aimed at hitting breakeven by end‑2026. That framing helps explain why some investors are looking past near‑term red ink toward execution milestones in 2026–2027. Benzinga Post‑earnings sentiment check: Separate coverage today noted that analyst targets have been adjusted following last week’s report, with attention on how quickly the company can translate higher acquisitions into improved unit economics. Simply Wall St The week’s big
10 November 2025
Intel (INTC) News Today — Nov. 10, 2025: Ex‑Engineer “Top Secret” Data Lawsuit; INTC Rises as Shutdown Deal Lifts Tech

Intel (INTC) News Today — Nov. 10, 2025: Ex‑Engineer “Top Secret” Data Lawsuit; INTC Rises as Shutdown Deal Lifts Tech

INTC today: price snapshot As of 14:12 UTC on Monday, Intel (NASDAQ: INTC) traded around $38.13, up ~2.4% on the session as risk appetite improved with Washington progress on a funding deal. 1) Intel files suit over alleged theft of “Top Secret” data Intel has sued former software engineer Jinfeng Luo, alleging he downloaded roughly 18,000 internal files—some labeled “Intel Top Secret”—to a network‑attached storage device days before his termination, then went off the grid. The U.S. District Court (W.D. Washington) docket shows Intel filed the complaint Oct. 31, 2025. Press coverage of the case intensified yesterday and today, with
10 November 2025

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop